Drug Res (Stuttg) 2014; 64(08): 448
DOI: 10.1055/s-0034-1375636
Erratum
© Georg Thieme Verlag KG Stuttgart · New York

The Relationship between Anagliptin Concentration Showing Over 80% Inhibition of Plasma Dipeptidyl Peptidase-4 Activity and its Protective Effect against Glucagon-like Peptide-1 Degradation

S. Furuta
1   Sanwa Kagaku Kenkyusho, Co. Ltd, Pharmaceutical Research Laboratories, Mie, Japan
,
M. Goto
1   Sanwa Kagaku Kenkyusho, Co. Ltd, Pharmaceutical Research Laboratories, Mie, Japan
,
M. Tamura
1   Sanwa Kagaku Kenkyusho, Co. Ltd, Pharmaceutical Research Laboratories, Mie, Japan
,
S. Yamashita
1   Sanwa Kagaku Kenkyusho, Co. Ltd, Pharmaceutical Research Laboratories, Mie, Japan
,
K. Nakaya
1   Sanwa Kagaku Kenkyusho, Co. Ltd, Pharmaceutical Research Laboratories, Mie, Japan
,
Y. Furuta
1   Sanwa Kagaku Kenkyusho, Co. Ltd, Pharmaceutical Research Laboratories, Mie, Japan
› Author Affiliations
Further Information

Publication History

Publication Date:
05 May 2014 (online)

Erratum

The Relationship between Anagliptin Concentration Showing Over 80% Inhibition of Plasma Dipeptidyl Peptidase-4 Activity and its Protective Effect against Glucagon-like Peptide-1 Degradation

S. Furuta, M. Goto, M. Tamura, S. Yamashita, K. Nakaya, Y. Furuta

DOI: 10.1055/s-0033-1353185

Drug Res 2014; 64: 130–135

© Georg Thieme Verlag KG

The authors claim that a mistake occured in the article “The Relationship between Anagliptin Concentration Showing Over 80% Inhibition of Plasma Dipeptidyl Peptidase-4 Activity and its Protective Effect against Glucagon-like Peptide-1 Degradation”.

They want to remove the significance mark (#) for sitagliptin, high vs. low dose, on P133, Fig. 3c. With the deletion, they want to delete “significantly” and “p<0.05” in the text on P133, right column, end of second chapter, and on P134, right column, line 18.